Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1647 of 6351
-
A painkiller duo that could sidestep opioids after hand surgery?
Symptom relief Recruiting nowThe purpose of this study is to learn about the effectiveness of different pain control options after hand and wrist surgery, specifically Ketorolac, Tylenol, and a regional nerve block. Ketorolac (Toradol) is a nonsteroidal anti-inflammatory drug (NSAID) that is similar to ibupr…
Phase 4 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Experimental HIV vaccine enters human testing – could it train the body to fight the virus?
Vaccine Recruiting nowThis is a partially randomized, open-label phase 1 study to evaluate the safety and immunogenicity of a priming regimen of 426c.Mod.Core-C4b adjuvanted with 3M-052 AF + Alum followed by boosts with HxB2.WT.Core-C4b adjuvanted with 3M-052 AF + Alum. The primary hypothesis is that…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 07:51 UTC
-
Heart ultrasound may uncover silent AFib in thousands
Diagnosis Recruiting nowTo evaluate the feasibility of specific echocardiographic parameters as criteria for AF screening and to determine the AF detection yield of scheduled extended ECG monitoring compared to contemporary care.
Sponsor: Tze-Fan Chao • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
Can a bright lamp lift teen depression? new study tests home light therapy
Symptom relief Recruiting nowMajor Depressive Disorder (MDD) is a chronic disease characterized by a high prevalence, low cure rate, and significant disability. Globally, depression is recognized as the leading cause of illness and disability among children and adolescents. Bright light therapy (BLT) has bee…
Sponsor: Peking University Sixth Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New device lets spinal injury patients stimulate nerves at home to improve hand use
Disease control CompletedThis is a multi-center, observational, single-arm, 6-week home study to evaluate the safety and efficacy of transcutaneous spinal cord stimulation via the ExaStim system for 4 consecutive weeks used in the home setting for individuals with traumatic spinal cord injury. The study …
Sponsor: Niche Biomedical, Inc. dba ANEUVO • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New antibody drug aims to cut COPD attacks in half
Disease control OngoingThe study is a Phase II, multicenter, double-blind, randomized, parallel, placebo-controlled clinical trial designed to evaluate the efficacy, safety, tolerability, and pharmacokinetic characteristics of TQC2938 in patients with moderate to severe Chronic Obstructive Pulmonary Di…
Phase 2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New hope for Women's pelvic pain: light and physiotherapy put to the test
Symptom relief Recruiting nowThis trial will provide evidence for the effective management of pain and pain-related domains among those who experience provoked vestibulodynia (PVD) using photobiomodulation (PBM) and multimodal physiotherapy (mPT) in a randomized controlled trial (RCT). PVD is the most common…
Sponsor: University of Ottawa • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Boosting breastfeeding confidence in teen moms: a new approach put to the test
Disease control CompletedAdolescence is the period between the ages of 10 and 19, during which individuals undergo physiological, biological, psychological, and social development, transitioning from childhood to adulthood. Pregnancies occurring during this period are defined as adolescent pregnancies. I…
Sponsor: Saglik Bilimleri Universitesi • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New cell therapy HN2301 enters human trials for autoimmune diseases
Disease control Recruiting nowThis is an open lable and single arm study, is designed to evaluate the safety and preliminary efficacy of HN2301 in Autoimmune Disease(AID)
Phase 1 • Sponsor: Shenzhen MagicRNA Biotechnology Co., Ltd • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can hormone therapy change liver health? a new study investigates
Knowledge-focused By invitation onlyPrimary Objective: Assess disparities in liver health outcomes among transgender individuals on GAHT by evaluating liver function markers (transaminases, bilirubin levels, etc), as well as liver elasticity and presence of liver steatosis or Nonalcoholic Fatty Liver Disease (NAFL…
Sponsor: Corey DeStefano • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Heavier Warm-Up, higher jump? testing weighted plyometrics in soccer
Knowledge-focused CompletedExplosive lower-limb power is essential for soccer performance and contributes to jumping, sprinting, and rapid changes of direction. Plyometric exercises are commonly used during warm-up to improve neuromuscular readiness and may enhance subsequent athletic performance through p…
Sponsor: Istanbul Gelisim University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Virtual reality boxing and bowling could rebuild trunk control after stroke
Disease control CompletedThis research study aims to evaluate the effectiveness of Kinect-based upper extremity exergaming in improving trunk control, postural stability, upper limb function, and quality of life among individuals recovering from stroke. A randomized controlled trial will be conducted, en…
Sponsor: Foundation University Islamabad • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New glasses aim to stop kids from becoming nearsighted
Prevention OngoingEvaluate the efficacy, safety and wearing time compliance of novel plano spectacle lenses in delaying myopia onset in pre-myopic children and provide scientific basis for the development of myopia prevention strategies for children.
Sponsor: Shanghai Eye Disease Prevention and Treatment Center • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
New program aims to help Low-Income louisianans lose weight with coaching and community support
Disease control Recruiting nowThe goal of this clinical trial is to test the effectiveness of an evidence-based multi-level intervention for weight loss and the feasibility, fidelity, and sustainability of implementing the intervention in people living with obesity in Louisiana. The main questions it aims to …
Sponsor: Tulane University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can Platelet-Rich plasma heal stubborn wounds faster than saline?
Disease control CompletedThis randomized controlled trial will compare platelet rich plasma dressing with normal saline dressing for the treatment of chronic non healing cutaneous ulcers, including diabetic foot ulcers, venous leg ulcers, pressure ulcers, and other suitable chronic ulcers of at least six…
Sponsor: Multan Medical And Dental College • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New weekly shot shows promise for weight and diabetes control
Disease control CompletedThis study is designed to test how well once-weekly MET097 (an ultra-long-acting GLP-1 receptor agonist) works to treat adults with obesity or overweight and type 2 diabetes mellitus (T2DM) compared to placebo. MET097 or placebo will be administered to individuals via subcutaneou…
Phase 2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Sugar-Based gel shows promise for stroke patients in early trial
Disease control CompletedThe MaTRISS 2 study is a phase 2 randomized, double-blinded and placebo-controlled trial aimed at recruiting 60 subjects (30 placebo and 30 active) from 15 stroke centers in France. The main objective will be to assess the efficacy of OTR4132-MD in patients with anterior ischemic…
Phase 2 • Sponsor: Organ, Tissue, Regeneration, Repair and Replacement • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New weekly injection shows promise for obesity – phase 2 trial complete
Disease control CompletedThis randomized, double-blind, parallel, placebo-controlled phase II study to evaluate the efficacy and safety of UBT251 Injection in overweight/obese patients
Phase 2 • Sponsor: The United Bio-Technology (Hengqin) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New pill could cut blood transfusions for MDS patients
Disease control Recruiting nowThis is a Phase 2, multicenter, randomized, open-lable, dose ranging study to evaluate the efficacy and safety of AND017 for the treatment of anemia due to lower risk Myelodysplastic syndromes (MDS) in patients subjects who are Red blood cell (RBC) non-transfusion dependent (NTD)…
Phase 2 • Sponsor: Kind Pharmaceuticals LLC • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Sound waves could spot hidden artery disease without needles or radiation
Diagnosis Recruiting nowThe purpose of this study is to develop a new noninvasive tool for early diagnosis of Peripheral Arterial Disease (PAD) and use the proposed method for monitoring the disease progression and the response to interventional treatment in PAD patients.
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC